AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H969-H974, 2004. First published March 25, 2004; doi:10.1152/ajpheart.01171.2003
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/2/H969    most recent
01171.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, S.
Right arrow Articles by Klouche, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, S.
Right arrow Articles by Klouche, K.

{delta}-Opioid receptor agonist reduces severity of postresuscitation myocardial dysfunction

Shijie Sun,1,2 Max Harry Weil,1,2 Wanchun Tang,1,2 Takashi Kamohara,1 and Kada Klouche1

1Institute of Critical Care Medicine, Palm Springs, 92262; and 2Keck School of Medicine, University of Southern California, Los Angeles, California 90089

Submitted 9 December 2003 ; accepted in final form 18 March 2004

Postresuscitation myocardial dysfunction is recognized as a leading cause of early death after initially successful cardiopulmonary resuscitation (CPR). In the present study, we hypothesized that a {delta}-opioid receptor agonist would decrease the severity of postresuscitation myocardial dysfunction and improve survival. Fifteen Sprague-Dawley rats, fasted overnight with access to water, were anesthetized by an injection of 45 mg/kg ip pentobarbital sodium. Additional doses of 10 mg/kg were administered at hourly intervals but not within 30 min before induced ventricular fibrillation (VF). Either the {delta}-opioid receptor agonist pentazocine (300 µg/kg), pentazocine pretreated with the opioid receptor-blocking agent naloxone (1 mg/kg), or saline placebo was injected into the right atrium after 5 min of untreated VF and 3 min before initiation of CPR. After an additional 8 min of CPR administration, defibrillation was attempted. All animals were successfully resuscitated. Left ventricular rate of pressure increase at 40 mmHg and cardiac index values were significantly improved in pentazocine-treated animals, which also had significantly longer survival times (60 ± 11 vs. 16 ± 7 h; P < 0.01). Except for ease of defibrillation, the beneficial effects of pentazocine were completely abolished by pretreatment with naloxone. The concept of pharmacological hibernation employing a {delta}-opioid receptor agonist is a novel and promising intervention for minimizing global ischemic injury during CPR and postresuscitation myocardial dysfunction.

cardiac arrest; cardiopulmonary resuscitation; hibernation; ventricular fibrillation; rat



Address for reprint requests and other correspondence: S. Sun, Institute of Critical Care Medicine, 1695 North Sunrise Way, Bldg. 3, Palm Springs, CA 92262 (E-mail: shijiesun{at}aol.com).




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
X. Fang, W. Tang, S. Sun, L. Huang, Y.-T. Chang, Z. Huang, and M. H. Weil
Cardiopulmonary resuscitation in a rat model of chronic myocardial ischemia
J Appl Physiol, October 1, 2006; 101(4): 1091 - 1096.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. A. El-Menyar
The Resuscitation Outcome: Revisit the Story of the Stony Heart
Chest, October 1, 2005; 128(4): 2835 - 2846.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.